Secondary Logo

Journal Logo

January-February 2001 - Volume 24 - Issue 1
pp: 1-98

Semiallogeneic Cancer Vaccines Formulated With Granulocyte-Macrophage Colony-Stimulating Factor for Patients With Metastatic Gastrointestinal Adenocarcinomas: A Pilot Phase I Study

Newton, Danforth A.; Acierno, Paula M.; Metts, Margaret C.; More

Journal of Immunotherapy. 24(1):19-26, January-February 2001.

Human Inflammatory Cells Within the Tumor Microenvironment of Lung Tumor Xenografts Mediate Tumor Growth Suppression in Situ that Depends on and Is Augmented by Interleukin-12

Sugiyama, Yasuyuki; Kato, Motohisa; Chen, Fang-An; More

Journal of Immunotherapy. 24(1):37-45, January-February 2001.


Phase I Pilot Trial of the Bispecific Antibody MDXH210 (anti-FcγRI X anti–HER-2/neu) in Patients Whose Prostate Cancer Overexpresses HER-2/neu

Schwaab, Thomas; Lewis, Lionel D.; Cole, Bernard F.; More

Journal of Immunotherapy. 24(1):79-87, January-February 2001.